![Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.]()
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.Middleton, M R; Grob, J J; Aaronson, N; Fierlbeck, G; Tilgen, W; Seiter, S; Gore, M; Aamdal, S; Cebon, J; Coates, a; Dreno, B; Henz, M; Schadendorf, D; Kapp, a; Weiss, J; Fraass, U; Statkevich, P; Muller, M; Thatcher, N · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2000